FARMINGDALE, N.Y.--(BUSINESS WIRE)--Aug. 23, 2006--Enzo Biochem, Inc. (NYSE:ENZ) announced today that the United States Patent and Trademark Office has declared two patent interferences designating an allowable Enzo Life Sciences patent application against patents held by Chiron Diagnostics and Princeton University for nucleic acid detection. Bayer Healthcare LLC, of Tarrytown, NY, is the real party in interest to Chiron’s patent. Enzo Life Sciences is the senior party in both interferences.
